These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 30779465

  • 1. Distribution of serum neuron-specific enolase and the establishment of a population reference interval in healthy adults.
    Liu Q, Fan J, Xu A, Yao L, Li Y, Wang W, Liang W, Yang F.
    J Clin Lab Anal; 2019 Jun; 33(5):e22863. PubMed ID: 30779465
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum neuron-specific enolase levels in preterm and term newborns and in infants 1-3 months of age.
    Abbasoglu A, Sarialioglu F, Yazici N, Bayraktar N, Haberal A, Erbay A.
    Pediatr Neonatol; 2015 Apr; 56(2):114-9. PubMed ID: 25315754
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma.
    Oishi S, Sato T.
    Cancer; 1988 Mar 15; 61(6):1167-70. PubMed ID: 3342373
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical significance of the measurement of serum neuron-specific enolase levels in patients with lung cancer].
    Yumoto Y, Shiota T, Tamai M, Okabe K, Kiura K, Shimoe T, Fujii M.
    Gan To Kagaku Ryoho; 1986 Jun 15; 13(6):2089-93. PubMed ID: 3013098
    [Abstract] [Full Text] [Related]

  • 8. The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis.
    Liu XM, Liu XH, Mao MJ, Liu YJ, Wang JY, Dai SQ.
    J Clin Lab Anal; 2021 Sep 15; 35(9):e23895. PubMed ID: 34233042
    [Abstract] [Full Text] [Related]

  • 9. Correction of serum NSE reference intervals includes the unidentified hemolysis sample: 1-year data analysis from healthcare individuals.
    Xie E, Zhang W, Xu H, Ling Y, Zhang Q, Pan S.
    J Clin Lab Anal; 2019 Nov 15; 33(9):e22997. PubMed ID: 31402486
    [Abstract] [Full Text] [Related]

  • 10. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F, Engelhardt-Fahrner U, Schneider A, Schumacher R, Zieschang J.
    In Vivo; 1991 Nov 15; 5(3):245-7. PubMed ID: 1893081
    [Abstract] [Full Text] [Related]

  • 11. [Clinical evaluation of serum neuron-specific enolase levels in patients with lung cancer].
    Mori Y, Hoshi H, Jinnouchi S, Harada K, Onoe K, Nagamachi S, Ozawa M, Watanabe K, Tawara Y.
    Radioisotopes; 1987 Feb 15; 36(2):78-80. PubMed ID: 3033753
    [Abstract] [Full Text] [Related]

  • 12. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
    Schmitt UM, Stieber P, Hasholzner U, Pahl H, Hofmann K, Fateh-Moghadam A.
    Eur J Clin Chem Clin Biochem; 1996 Aug 15; 34(8):679-82. PubMed ID: 8877347
    [Abstract] [Full Text] [Related]

  • 13. [Serum NSE (neuron-specific enolase) levels in small cell lung cancer, with special reference to the measurement of serial serum NSE levels].
    Kawachi S, Shimabukuro Z, Aoyama A, Yano T, Hasegawa K, Tsuboi E, Niitani H.
    Gan To Kagaku Ryoho; 1987 Aug 15; 14(8):2469-74. PubMed ID: 3039919
    [Abstract] [Full Text] [Related]

  • 14. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J, Høgetveit A, Wold Akselberg K, Vangsnes K, Paus E, Bjøro T, Børmer OP, Nustad K.
    Scand J Clin Lab Invest; 2008 Aug 15; 68(8):703-13. PubMed ID: 18609108
    [Abstract] [Full Text] [Related]

  • 15. Development of a new automated enzyme immunoassay for the determination of neuron-specific enolase.
    Sterk M, Oenings A, Eymann E, Roos W.
    Anticancer Res; 1999 Aug 15; 19(4A):2759-62. PubMed ID: 10470236
    [Abstract] [Full Text] [Related]

  • 16. The establishment of neuron-specific enolase reference interval for the healthy population in southwest China.
    Miao Q, Cai B, Gao X, Su Z, Zhang J.
    Sci Rep; 2020 Apr 14; 10(1):6332. PubMed ID: 32286436
    [Abstract] [Full Text] [Related]

  • 17. [Establishment of cut-off value of serum pro-gastrin-releasing peptide for diagnosis of small cell lung cancer and evaluation on the clinical diagnosis efficiency].
    Shen D, Han BB, Chen F, Wei BJ, Cui CJ, Wang GJ, Cui W.
    Zhonghua Yi Xue Za Zhi; 2017 Sep 12; 97(34):2657-2662. PubMed ID: 28910952
    [Abstract] [Full Text] [Related]

  • 18. Biological variation of neuroendocrine tumor markers chromogranin A and neuron-specific enolase.
    Braga F, Ferraro S, Mozzi R, Dolci A, Panteghini M.
    Clin Biochem; 2013 Jan 12; 46(1-2):148-51. PubMed ID: 23000312
    [Abstract] [Full Text] [Related]

  • 19. Serum neuron specific enolase (S-NSE) reference interval evaluation by time-resolved immunofluorometry compared with a radioimmunoassay.
    Jørgensen LG, Løber J, Carlsen NL, Momsen G, Hirsch FR.
    Clin Chim Acta; 1996 May 30; 249(1-2):77-91. PubMed ID: 8737594
    [Abstract] [Full Text] [Related]

  • 20. Serum and CSF neuron-specific enolase in patients with West syndrome.
    Suzuki Y, Toribe Y, Goto M, Kato T, Futagi Y.
    Neurology; 1999 Nov 10; 53(8):1761-4. PubMed ID: 10563625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.